| Status | Target/Acquirer | Position | Thesis summary | Spread | Downside | Added |
|---|---|---|---|---|---|---|
| New |
Adobe / Figma
US / US
|
↑ Long | DOJ likely to clear after EU approval; upside from regulatory e... | 12.5% | −3.8% | Oct 21 |
| Catalyst near |
Spirit Airlines / JetBlue
SAVE US / JBLU US
|
↓ Short | Deal unlikely to close before Q2'26 due to DOJ litigation | 9.2% | −7.1% | Oct 20 |
| Catalyst near |
Pfizer / Seagen
PFE US / SGEN US
|
↑ Short | CFIUS clearance expected in Nov; integration synergies intact | 6.7% | −2.9% | Oct 19 |
| New |
Exxent / Blackstone
EXNT US / BX US
|
↑ Long | Spread remains wide post definitive approval; limited downside | 11.4% | −6.3% | Oct 19 |
| Catalyst near |
Broadcom / VMware
AVGO US / VMW US
|
↑ Long | Final approval in China pending; high-probability close by yea... | 5.1% | −1.9% | Oct 19 |
| Catalyst near |
Horizon Therapeutics / Amgen
HZNP US / AMGN US
|
↓ Long | FTC settlement reduces upside; possible valuation revision | 8.4% | −6.7% | Oct 18 |
| New |
Splunk / Cisco
SPLK US / CSCO US
|
↑ Long | Regulatory review smooth; expected close in H1'26 | 14.9% | −5.2% | Oct 18 |
| New |
Tapestry / Capri Holdings
TPR US / CPRI US
|
↑ Long | EU filing accepted; U.S. review ongoing; decision early 2026 | 10.3% | −3.4% | Oct 17 |
| New |
Illumina / GRAIL
ILMN US / Private
|
↓ Long | EC order may force divestiture; valuation headwinds remain | 7.8% | −8.1% | Oct 16 |
| Catalyst near |
Kroger / Albertsons
KR US / ACI US
|
↓ Short | FTC trial in progress; significant regulatory pushback expected | 6.6% | −6.0% | Oct 15 |
Recent Updates to Top Ideas
| Updates | Thesis summary | Date |
|---|---|---|
| Added |
STAAR Surgical (STAA) / Alcon (ALC-SW)
added to Americas Top Ideas. Thesis: Opposing shareholders, vote likely to fail
|
Oct 21 |
| Removed |
Adobe (ADBE) / Figma
removed from Americas Top Ideas. Reason: Deal terminated due to regulatory concerns
|
Sep 05 |
| Comment |
Cross Country (CCRN) / Aya Healthcare
deal view remains unchanged despite recent market volatility. Antitrust review remains the key focus
|
Jul 12 |
Top Idea
Allegro MicroSystems Inc AMED US
UnitedHealth Group Inc UNH US
Top Idea
Allegro MicroSystems Inc AMED US
UnitedHealth Group Inc UNH US
Top Idea
Allegro MicroSystems Inc AMED US
UnitedHealth Group Inc UNH US